Concepedia

Tatjana Bilich

TB

12

Publications

1.7K

Citations

11

H-Index

2016

Active since

Affiliations

University of Tübingen(Current)

Deutschen Konsortium für Translationale Krebsforschung

German Cancer Research Center

University Children's Hospital Tübingen

Immatics Biotechnologies (Germany)

Tatjana Bilich is an author at University of Tübingen specializing in immunology, medicine, and covid-19.

ORCID

Top concepts

Publications per year

2016–2022

12

Publications

12

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Annika Nelde, Tatjana Bilich, Jonas S. Heitmann et al. · Nature Immunology · 2020 · 630 citations

, , +2

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

Jonas S. Heitmann, Tatjana Bilich, Claudia Tandler et al. · Nature · 2021 · 268 citations · Full text

The immunopeptidomic landscape of ovarian carcinomas

Heiko Schuster, Janet K. Peper-Gabriel, H. Bösmüller et al. · Proceedings of the National Academy of Sciences · 2017 · 187 citations · Full text

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals

Tatjana Bilich, Annika Nelde, Jonas S. Heitmann et al. · Science Translational Medicine · 2021 · 166 citations · Full text

Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer

Clemens Hinterleitner, Jasmin Strähle, Elke Malenke et al. · Nature Communications · 2021 · 158 citations · Full text

Rows per page

1–5 of 12